
New Cancer Therapy: FDA grants priority review of glofitamab for lymphoma
New Cancer Therapy: The US Food and Drug Administration (FDA) has granted the review of glofitamab. It will be reviewed for relapsed or refractory large […]
New Cancer Therapy: The US Food and Drug Administration (FDA) has granted the review of glofitamab. It will be reviewed for relapsed or refractory large […]
New Cancer Therapy: The recent research publication in the Proceedings of the National Academy of Sciences has presented the concept of predicting breast cancer treatment […]
Global Healthcare trends: A meeting took place on 30 December between WHO and China. It focus on discussing the current situation of China due to […]
Copyright © 2023 | WordPress Theme by MH Themes